Dr. Mark Gentry, MD

NPI: 1144260191
Total Payments
$5,634
2024 Payments
$352.85
Companies
44
Transactions
188
Medicare Patients
260
Medicare Billing
$22,584

Payment Breakdown by Category

Food & Beverage$3,931 (69.8%)
Other$1,500 (26.6%)
Education$134.21 (2.4%)
Travel$69.43 (1.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,931 175 69.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,500 1 26.6%
Education $134.21 10 2.4%
Travel and Lodging $69.43 2 1.2%

Top Paying Companies

Company Total Records Latest Year
Roche Diagnostics Corporation $1,668 7 $0 (2019)
ABBVIE INC. $637.42 19 $0 (2023)
Novo Nordisk Inc $374.20 12 $0 (2024)
Astellas Pharma US Inc $277.55 16 $0 (2024)
AMAG Pharmaceuticals, Inc. $268.58 11 $0 (2020)
PFIZER INC. $243.79 14 $0 (2023)
Sumitomo Pharma America, Inc. $216.63 10 $0 (2024)
CooperSurgical, Inc. $206.11 6 $0 (2023)
Minerva Surgical, Inc $147.44 2 $0 (2023)
Duchesnay USA Incorporated $138.74 9 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $352.85 12 Novo Nordisk Inc ($176.03)
2023 $689.96 30 Sumitomo Pharma America, Inc. ($153.42)
2022 $410.26 23 PFIZER INC. ($84.37)
2021 $341.34 14 AbbVie Inc. ($121.30)
2020 $184.64 9 AbbVie Inc. ($121.35)
2019 $635.74 22 AbbVie, Inc. ($245.29)
2018 $667.16 31 AMAG Pharmaceuticals, Inc. ($193.93)
2017 $2,353 47 Roche Diagnostics Corporation ($1,607)

All Payment Transactions

188 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/10/2024 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $20.75 General
Category: HORMONE THERAPY
09/09/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $22.81 General
Category: Biological
08/28/2024 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $21.23 General
Category: HORMONE THERAPY
08/22/2024 Biogen, Inc. ZURZUVAE (Drug) Food and Beverage In-kind items and services $21.66 General
Category: Neurology
07/31/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $121.18 General
Category: Obesity
07/31/2024 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $21.23 General
Category: HORMONE THERAPY
07/29/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $18.78 General
Category: Obesity
06/25/2024 Hologic Sales and Service, LLC NOVASURE (Device), FLUENT FLUID MANAGEMENT SYSTEM, OMNI HYSTEROSCOPE Food and Beverage In-kind items and services $20.36 General
Category: Surgical
06/04/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $18.77 General
Category: Obesity
03/26/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $26.01 General
Category: Hematology
03/19/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $17.30 General
Category: Obesity
01/15/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $22.77 General
Category: Biological
12/05/2023 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $24.58 General
Category: Oncology
11/28/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $24.58 General
Category: HORMONE THERAPY
11/14/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $19.76 General
Category: Biological
10/31/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $23.53 General
Category: HORMONE THERAPY
09/20/2023 Axonics, Inc. Axonics (Device) Food and Beverage In-kind items and services $20.66 General
Category: Urology
08/23/2023 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $31.79 General
08/15/2023 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $20.75 General
08/15/2023 CooperSurgical, Inc. PARAGARD T 380A (Drug) Food and Beverage In-kind items and services $17.94 General
Category: Endocrinology
08/15/2023 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $16.13 General
Category: Obesity
08/09/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $24.58 General
Category: HORMONE THERAPY
08/01/2023 Exeltis, USA Inc. SLYND (Drug) Food and Beverage In-kind items and services $12.69 General
Category: Oral Contraceptive
06/26/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $20.52 General
Category: HORMONE THERAPY
06/13/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $20.35 General
Category: HORMONE THERAPY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 62 97 $10,533 $5,843
2022 3 65 108 $11,184 $6,062
2021 4 73 117 $12,940 $6,753
2020 3 60 85 $8,779 $3,926
Total Patients
260
Total Services
407
Medicare Billing
$22,584
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 35 66 $5,940 $3,920 66.0%
76830 Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina Office 2023 13 17 $3,893 $1,411 36.3%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2023 14 14 $700.00 $511.56 73.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 32 73 $6,570 $4,171 63.5%
76830 Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina Office 2022 14 16 $3,664 $1,193 32.6%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2022 19 19 $950.00 $697.90 73.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 27 65 $5,850 $3,784 64.7%
76830 Ultrasound pelvis through vagina Office 2021 18 19 $4,351 $1,373 31.5%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 17 22 $1,232 $883.94 71.7%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 11 11 $1,507 $712.35 47.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 27 52 $4,680 $2,333 49.8%
76830 Ultrasound pelvis through vagina Office 2020 13 13 $2,977 $841.79 28.3%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2020 20 20 $1,122 $751.80 67.0%

About Dr. Mark Gentry, MD

Dr. Mark Gentry, MD is a Obstetrics & Gynecology healthcare provider based in Danville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144260191.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Gentry, MD has received a total of $5,634 in payments from pharmaceutical and medical device companies, with $352.85 received in 2024. These payments were reported across 188 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($3,931).

As a Medicare-enrolled provider, Gentry has provided services to 260 Medicare beneficiaries, totaling 407 services with total Medicare billing of $22,584. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics & Gynecology
  • Location Danville, IN
  • Active Since 06/07/2006
  • Last Updated 03/04/2021
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1144260191

Products in Payments

  • MD cobas Instruments and Reagents (Device) $1,668
  • Wegovy (Drug) $323.26
  • MYFEMBREE (Drug) $288.30
  • ORILISSA (Drug) $262.90
  • Orilissa (Drug) $245.29
  • PREMARIN (Drug) $173.25
  • INTRAROSA (Drug) $172.13
  • LO LOESTRIN FE (Drug) $133.81
  • Endometrial Ablation System (Device) (Device) $133.10
  • DIVIGEL (Drug) $128.26
  • ADDYI (Drug) $120.21
  • Myrbetriq (Drug) $116.03
  • ANNOVERA (Drug) $115.50
  • Da Vinci Surgical System (Device) $93.57
  • Point-of-Care Products (Device) $92.75
  • Veozah (Drug) $84.17
  • INJECTAFER (Drug) $83.71
  • Diclegis (Drug) $79.60
  • Paragard (Device) $73.39
  • NUVARING (Drug) $72.30

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Danville